STRN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.103000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.118600E-01
Normal-vs-Stage2
9.963400E-01
Normal-vs-Stage3
1.021840E-01
Normal-vs-Stage4
3.325800E-01
Stage1-vs-Stage2
8.789600E-01
Stage1-vs-Stage3
1.319000E-01
Stage1-vs-Stage4
1.820780E-01
Stage2-vs-Stage3
1.054810E-01
Stage2-vs-Stage4
7.212000E-02
Stage3-vs-Stage4
4.353600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.793400E-01
Normal-vs-AfricanAmerican
4.753600E-01
Normal-vs-Asian
3.220400E-01
Caucasian-vs-AfricanAmerican
7.819500E-02
Caucasian-vs-Asian
2.130800E-01
AfricanAmerican-vs-Asian
3.794000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.308400E-01
Normal-vs-Female
8.862000E-01
Male-vs-Female
8.182000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.284800E-01
Normal-vs-Age(41-60Yrs)
7.811400E-01
Normal-vs-Age(61-80Yrs)
7.797000E-01
Normal-vs-Age(81-100Yrs)
4.859200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.692400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.127200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.866200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.493800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.117190E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.790600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.730800E-01
Normal-vs-Daily Drinker
6.284400E-01
Normal-vs-Weekly Drinker
8.314600E-01
Normal-vs-Occasional Drinker
9.292800E-01
Normal-vs-Social Drinker
9.065400E-01
Non Drinker-vs-Daily Drinker
7.789600E-01
Non Drinker-vs-Weekly Drinker
8.330200E-01
Non Drinker-vs-Occasional Drinker
3.145600E-01
Non Drinker-vs-Social Drinker
3.187800E-01
Daily Drinker-vs-Weekly Drinker
7.015200E-01
Daily Drinker-vs-Occasional Drinker
2.855800E-01
Daily Drinker-vs-Social Drinker
2.833000E-01
Weekly Drinker-vs-Occasional Drinker
5.953000E-01
Weekly Drinker-vs-Social Drinker
5.801200E-01
Occasional Drinker-vs-Social Drinker
9.599800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.877200E-01
Normal-vs-Grade 2
8.708400E-02
Normal-vs-Grade 3
3.726400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.521380E-01
Grade 1-vs-Grade 3
1.614280E-02
Grade 1-vs-Grade 4
2.877200E-01
Grade 2-vs-Grade 3
9.738400E-02
Grade 2-vs-Grade 4
8.708400E-02
Grade 3-vs-Grade 4
3.726400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.486200E-01
Normal-vs-NonDiabetic
6.864000E-01
Diabetic-vs-NonDiabetic
6.251200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.507800E-01
Normal-vs-NoPancreatitis
7.930000E-01
Pancreatitis-vs-NoPancreatitis
6.478400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.793000E-01
Normal-vs-N1
9.889800E-01
N0-vs-N1
3.012400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.947200E-01
Normal-vs-TP53-NonMutant
9.997000E-01
TP53-Mutant-vs-TP53-NonMutant
1.795030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
